TMCnet News
Research and Markets: Opioid Induced Bowel Dysfunction Pipeline Insights 2015Research and Markets (http://www.researchandmarkets.com/research/7bn87b/opioid_induced) has announced the addition of the "Opioid Induced Bowel Dysfunction-Pipeline Insights, 2014" subscription to their offering. This Opioid Induced Bowel Dysfunction-Pipeline Insights report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish the understanding for all the pipeline drugs that fall under Opioid Induced Bowel Dysfunction. This report provides information on the therapeutic development based on the Opioid Induced Bowel Dysfunction dealing with all the pipeline drugs, comparative analysis at various stages covering Filed, Phase III, Phase II, Phase I, IND filed, Preclinical, Discovery andunknown stages, therapeutics assessment by monotherapy and combination products and molecule type drug information. The report also covers the companies information involved in the therapeutic development of the products. It also has highlighted the discontinued and dormant products. Key Topics Covered:
For more information visit http://www.researchandmarkets.com/research/7bn87b/opioid_induced
|